Gadgeel S;
Shaw AT;
Barlesi F;
Crino L;
Yang JCH;
Dingemans AM;
Kim DW;
de Marinis F;
Schulz M;
Liu S;
Gupta R;
Smoljanovic V;
Ou SHI
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies
Contributor:
Gadgeel S;
Shaw AT;
Barlesi F;
Crino L;
Yang JCH;
Dingemans AM;
Kim DW;
de Marinis F;
Schulz M;
Liu S;
Gupta R;
Smoljanovic V;
Ou SHI
Published:
2019
Published in:
Lung Cancer: Targets and Therapy (2019), Seite 125-130